QHSLab, Inc. operates as a medical device technology and software as a service company. The company is headquartered in West Palm Beach, Florida and currently employs 12 full-time employees. The company went IPO on 2002-01-09. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. The company also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The firm sells allergy diagnostic-related products and immunotherapy treatments to physicians.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
09/30/2025
06/30/2025
09/30/2024
06/30/2024
Revenue
2
0
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
--
--
Cost of Revenue
0
0
0
0
0
0
Gross Profit
1
0
0
0
0
0
Selling, General & Admin
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
Operating Expenses
1
0
0
0
0
0
Other Non Operating Income (Expenses)
0
0
--
--
--
--
Pretax Income
0
0
0
0
0
0
Income Tax Expense
--
--
--
--
--
--
Net Income
0
0
0
0
0
0
Net Income Growth
--
--
--
--
--
--
Shares Outstanding (Diluted)
43.61
43.61
19.32
11.28
18.53
10.21
Shares Change (YoY)
--
--
4%
10%
99%
10%
EPS (Diluted)
0
0.01
0
0
0
0
EPS Growth
--
--
-37%
1,467%
-130%
-97%
Free Cash Flow
0
0
0
0
0
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
50%
0%
0%
0%
0%
0%
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
0%
0%
EBITDA
0
0
0
0
0
0
EBITDA Margin
0%
0%
0%
0%
0%
0%
D&A For EBITDA
0
0
0
0
0
0
EBIT
0
0
0
0
0
0
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
--
--
--
--
--
--
Follow-Up Questions
What are QHSLab Inc's key financial statements?
According to the latest financial statement (Form-10K), QHSLab Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for USAQ?
QHSLab Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is QHSLab Inc's revenue broken down by segment or geography?
QHSLab Inc largest revenue segment is Allergy Diagnostic Kit, at a revenue of 666,600 in the most earnings release.For geography, United States is the primary market for QHSLab Inc, at a revenue of 1,408,995.
Is QHSLab Inc profitable?
no, according to the latest financial statements, QHSLab Inc has a net loss of $0